Solinas Medical is focused on developing innovative vascular access technologies aimed at improving outcomes for patients undergoing hemodialysis. Their flagship product, the ReTAP AV Graft, is designed to address the significant costs and complications associated with traditional vascular access methods. The ReTAP AV Graft features one or two specialized ReTAP zones that enhance sealing performance and are fully integrated with ePTFE tubing, which optimizes hemocompatibility and suture-ability. This design minimizes the risk of blood or fluid accumulation, thereby improving leak resistance and allowing for early cannulation. The ReTAP AV Graft maintains traditional surgical and cannulation methods, facilitating easier and more effective hemodialysis treatment.

The company recognizes the financial burden of vascular access complications, particularly in patients with end-stage renal disease (ESRD), who represent a small percentage of Medicare beneficiaries but incur substantial healthcare costs. By leveraging the ReTAP AV Graft's advanced design, Solinas Medical aims to reduce the reliance on tunneled dialysis catheters and associated hospitalizations, ultimately leading to significant cost savings and improved patient outcomes. The ReTAP AV Graft is available in various sizes and configurations to accommodate different anatomical placements, further enhancing its versatility in clinical settings.

United States

Solinas Medical is a medical device company that specializes in modernizing vascular access technology for hemodialysis, with a focus on reducing cannulation-related complications and healthcare costs.

Solinas Medical

Company Details